Discover 1,421 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,421
FeaturedActive & Responsive
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics
Sex: All
Age: 18+
Code: NCT07209475
Recruiting
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
for
Neisseria Meningitidis
Location: 1 recruiting location
Sponsor: Emory University
Sex: All
Age: 18 - 25
Code: NCT07197762
Recruiting
Active & ResponsiveNew
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia
for
Major Depressive Disorder
Location: 2 recruiting locations
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase2, Recruiting
Active & Responsive
A PIVOTAL STUDY EVALUATING SAFETY and EFFICACY of the SHIRATRONICS MIGRAINE THERAPY SYSTEM
for
Headache Migraine Chronic
Location: 15 recruiting locations
Sponsor: ShiraTronics
Sex: All
Age: 22+
Code: NCT06167655
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Shoulder Innovations Clinical Data Registry
for
Shoulder Arthroplasty
Location: 5 recruiting locations
Sponsor: Shoulder Innovations
Sex: All
Age: 18+
Code: NCT06754150
Recruiting
Active & Responsive
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
for
Degenerative Disc Disease
Location: 39 recruiting locations
Sponsor: Mesoblast, Ltd.
Sex: All
Age: 18+
Code: NCT06325566
Phase3, Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: 16 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase3, Recruiting
Active & Responsive
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy